Presentation is loading. Please wait.

Presentation is loading. Please wait.

30 patient drug sensitivity data Figure S1. Figure S2A Myeloid regulator enrichment in AML.

Similar presentations


Presentation on theme: "30 patient drug sensitivity data Figure S1. Figure S2A Myeloid regulator enrichment in AML."— Presentation transcript:

1 30 patient drug sensitivity data Figure S1

2 Figure S2A Myeloid regulator enrichment in AML

3 Figure S2B Myeloid regulator enrichment in cALL

4 Figure S2C Myeloid regulator enrichment in CLL

5 Figure S2D Myeloid regulator enrichment in MDS

6 Figure S3A Malacards AML

7 Figure S3B Malacards cALL

8 Figure S3C Malacards CLL

9 Figure S3D Malacards MDS

10 Figure S4A CGC AML

11 Figure S4B CGC cALL

12 Figure S4C CGC CLL

13 Figure S4D CGC MDS

14 Figure S5

15 Figure S6

16 Figure S7

17 Figure S8 Apoptosis AML

18 Signal transduction Immune response Mitochondrial function Celluar cytoskeleton Heme biosynthesis Figure S9

19 BCL-2 BAX Known anti-apoptotic factors A key mitochondrial pro- apoptotic protein Ohtsuka et al (2004) PYCARD Apoptosis SER in AML A key mediator in apoptosis and inflammation Youle et al (2008) FIGURE S10

20 Figure S11

21 Figure S12

22 Figure S13

23 Figure S14


Download ppt "30 patient drug sensitivity data Figure S1. Figure S2A Myeloid regulator enrichment in AML."

Similar presentations


Ads by Google